These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
80 related items for PubMed ID: 995305
21. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase. Ng SF, Waxman DJ. Cancer Res; 1990 Feb 01; 50(3):464-71. PubMed ID: 2105156 [Abstract] [Full Text] [Related]
23. Biliary excretion of drugs: role of ligandin in newborn immaturity and in the action of microsomal enzyme inducers. Klaassen CD. J Pharmacol Exp Ther; 1975 Nov 20; 195(2):311-9. PubMed ID: 1185600 [Abstract] [Full Text] [Related]
24. Enzyme induction by drugs. Its relevance to clinical biochemistry. Marshall WJ. Ann Clin Biochem; 1978 Jan 20; 15(1):55-64. PubMed ID: 343704 [Abstract] [Full Text] [Related]
25. Environmental factors in drug metabolism. Gillette JR. Fed Proc; 1976 Apr 20; 35(5):1142-7. PubMed ID: 1261708 [Abstract] [Full Text] [Related]
32. Age differences affecting induction of hepatic drug metabolizing enzymes by methaqualone and phenobarbital in the rat. Mathur PP, Boren JA, Smyth RD, Reavey-Cantwell NH. Res Commun Chem Pathol Pharmacol; 1975 May 20; 11(1):39-44. PubMed ID: 1153862 [Abstract] [Full Text] [Related]
33. In vitro metabolism of L-696,229, an HIV-1 reverse transcriptase inhibitor in rats and humans. Hepatic and extrahepatic metabolism and identification of enzymes involved in the hepatic metabolism. Prueksaritanont T, Dwyer LM, Balani SK, Theoharides AD. Drug Metab Dispos; 1994 May 20; 22(2):281-8. PubMed ID: 7516854 [Abstract] [Full Text] [Related]
34. Embryonic turkey liver: activities of biotransformation enzymes and activation of DNA-reactive carcinogens. Perrone CE, Ahr HJ, Duan JD, Jeffrey AM, Schmidt U, Williams GM, Enzmann HH. Arch Toxicol; 2004 Oct 20; 78(10):589-98. PubMed ID: 15167984 [Abstract] [Full Text] [Related]
35. Modulation of thiotepa antitumor activity in vivo by alteration of liver cytochrome P450-catalyzed drug metabolism. Chang TK, Chen G, Waxman DJ. J Pharmacol Exp Ther; 1995 Jul 20; 274(1):270-5. PubMed ID: 7616408 [Abstract] [Full Text] [Related]
36. Strychnine and brucine as the potent inducers of drug metabolizing enzymes in rat liver: different profiles from phenobarbital on the induction of cytochrome P450 and UDP-glucuronosyltransferase. Fujisaki H, Mise M, Ishii Y, Yamada H, Oguri K. J Pharmacol Exp Ther; 1994 Feb 20; 268(2):1024-31. PubMed ID: 7906730 [Abstract] [Full Text] [Related]
37. Effects of enzyme induction therapy on glucose and drug metabolism in obese mice model of non-insulin dependent diabetes mellitus. Karvonen I, Stengård JH, Huupponen R, Stenbäck FG, Sotaniemi EA. Diabetes Res; 1989 Feb 20; 10(2):85-92. PubMed ID: 2501061 [Abstract] [Full Text] [Related]
38. Effect of phenobarbital on jaundice. Schwartz GR. N Engl J Med; 1967 Aug 17; 277(7):375. PubMed ID: 4378278 [No Abstract] [Full Text] [Related]
39. [Liver and metabolism of drugs]. Darnis F. Cah Med; 1974 Oct 15; 15(10):637-43. PubMed ID: 4455367 [No Abstract] [Full Text] [Related]
40. [Therapeutic induction of hepatic enzymes]. Yamamoto T, Adachi Y. Nihon Rinsho; 1978 May 15; Suppl():2178-9. PubMed ID: 691684 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]